Tranexamic Acid: Finance

Summary

To ask the Secretary of State for Defence, pursuant to the answer of 14 September 2026 to question 27305 on Tranexamic Acid: Finance, what progress he has made in attaining regulatory approval from the Medicines and Healthcare products Regulatory Agency.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 9 October 2026

   Written question

   To ask the Secretary of State for Defence, pursuant to the answer of 14 September 2026 to question 27305 on Tranexamic Acid: Finance, what progress he has made in attaining regulatory approval from the Medicines and Healthcare products Regulatory Agency.

   Source: Commons

2. 19 October 2026

   Answer

   The Ministry of Defence and the Medicines and Healthcare products Regulatory Agency (MHRA) are engaged to facilitate the best way to progress the licencing of Tranexamic Acid (TXA) autoinjectors; both a novel dose and way of delivering TXA which has been ...

   Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

• Answer

  text · EN · 19 October 2026

  Open at official source

• Question

  text · EN · 9 October 2026

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• · Department of Health and Social Care · Answering body
• · Ministry of Defence · Answering body

Related records

No cross-record relationships stored yet.